BioStem Technologies, Inc.
BSEM
$4.38
-$0.46-9.60%
OTC PK
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 12.44M | 13.55M | 5.20M |
| Total Depreciation and Amortization | -- | -- | 256.70K | 295.20K | 251.90K |
| Total Amortization of Deferred Charges | -- | -- | 377.30K | 492.30K | 390.10K |
| Total Other Non-Cash Items | -- | -- | 7.48M | 4.11M | 7.87M |
| Change in Net Operating Assets | -- | -- | -5.65M | -3.49M | -8.61M |
| Cash from Operations | -- | -- | 14.90M | 14.95M | 5.10M |
| Capital Expenditure | -- | -- | -295.20K | -298.40K | -271.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -105.00K | -105.00K | -105.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -1.15M | -1.15M | 105.00K |
| Cash from Investing | -- | -- | -1.55M | -1.55M | -271.90K |
| Total Debt Issued | -- | -- | 60.90K | 60.90K | 549.40K |
| Total Debt Repaid | -- | -- | -1.20M | -1.24M | -1.38M |
| Issuance of Common Stock | -- | -- | 2.29M | 2.29M | 2.26M |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | -- | -- | 1.15M | 1.10M | 1.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | -- | -- |
| Net Change in Cash | -- | -- | 14.50M | 14.50M | 6.25M |